Milvue

Milvue is a French startup founded in 2018 that focuses on the intersection of AI and Information Technology in the healthcare industry. The company's slogan "NEW TECH, NEW CARE" underlines its commitment to leveraging technology to revolutionize patient care. Specifically, Milvue collaborates with healthcare community providers and manufacturers to address the evolving challenges in medical imaging. Their innovative approach involves developing an AI solution integrated into radiologists’ daily routines, aiming to facilitate quicker diagnoses, improved patient workflow management, and enhanced focus on patients. The company emphasizes that their AI solution is designed not to replace radiologists but to make them irreplaceable, emphasizing the human-centric approach to healthcare.

One of Milvue's notable achievements is the development of the Milvue Suite software, which has attained Class IIa medical device status in accordance with EU Regulation MDR 2017/745, with Notified Body: BSI, CE 2797. This certification underscores the company's commitment to meeting stringent regulatory standards in the healthcare technology space. Additionally, Milvue secured a significant €8.00M Series A investment on 15th December 2021, signifying strong investor confidence in the company's vision and capabilities. While the specific investors behind this round are not disclosed, the substantial funding underscores the potential and promise that Milvue holds in the intersection of AI and healthcare.

Overall, Milvue's dedication to leveraging AI for the betterment of healthcare, combined with its recent investment milestone, positions the company as a noteworthy player in the evolving landscape of medical technology.